BOOK value $7.60 per share, page-8

We owned MCS and some major Pharm companies under contract using our services back then , state of the art manufacturing complex cost millions to update buy new pharmaceutical specialized equipment after purchasing large adjoining parcel of land to allow for expansion to our existing manufacturing plant this expansion doubled our existing US plant relatively small in comparison to others into a much larger manufacturing pharma complex , millions of dollars spent on this expansion and never gets a mention when management bangs on about achieving a good price for MCS it was worth all of what we sold it for and more , cost to build / expand , equip , establish and also get other US major pharma companies under contract and use our services . Mayne valuation from what it was when we owned MCS very different from then to now , of course company is not valued what it was once , the considerable growth by going offshore into the US company grew considerably at our expense zero share value growth to allow for company growth now wiped out after selling we're pretty much dependent now on how well our products perform . Still operating at a high net loss how can we expect to be valued any higher than we are hopefully they will , who knows .